Dimenso Raises €600K Seed to Capture Lab Science with AI and Smart Glasses

Dimenso Secures €600K Seed Round

Dimenso, an AI infrastructure company focused on capturing and structuring scientific work in laboratories, has raised €600,000 in seed funding. The round was led by Draper B1, with participation from Next Tier Ventures.

What Dimenso Does

Dimenso builds AI infrastructure that captures and structures scientific work in laboratories in real time. The platform uses voice and computer vision, including smart glasses worn at the bench, to record actions, measurements, and observations. It then turns those inputs into structured, traceable records that sync with electronic lab notebook (ELN) and laboratory information management system (LIMS) platforms such as Benchling and LabArchives.

The approach targets a longstanding bottleneck in laboratory operations: the manual, fragmented capture of experimental detail. By recording activity as it happens and converting it into structured data, Dimenso aims to make scientific records more complete and traceable while reducing the burden on researchers.

Founders and Location

Dimenso was founded by Luis Alvear and Alvaro Buitrago. The company operates from Kendall Square in Cambridge, Massachusetts, and works with biotech, pharmaceutical, and academic laboratories in the US and Spain.

Funding Details

• Round type: Seed
• Amount: €600,000
• Lead investor: Draper B1
• Additional investors: Next Tier Ventures
• Announced date: September 7, 2026

Why This Matters for the Lab Tech Market

Laboratory digitization has become a priority for biotech, pharma, and academic research organizations seeking reproducibility, compliance, and operational efficiency. ELN and LIMS platforms have become standard infrastructure, but the data that feeds them often depends on manual entry or retrospective documentation.

Dimenso's focus on real-time capture via voice and computer vision positions it at the point of data creation—the bench itself. Its integration with established systems like Benchling and LabArchives suggests a strategy of augmenting, rather than replacing, existing laboratory software stacks.

The use of smart glasses is a notable differentiator. Hands-free capture is particularly relevant in laboratory environments where researchers work with instruments, samples, and reagents, and where stopping to type notes can interrupt workflow or introduce gaps in the record.

Acquisition Perspective

For acquirers in laboratory software, scientific instrumentation, or life sciences data infrastructure, Dimenso represents an early-stage asset with a focused technical thesis: real-time, multimodal capture of lab activity that feeds structured records into incumbent systems.

The company's seed-stage profile, dual-market presence in the US and Spain, and integration-first approach to ELN and LIMS platforms make it relevant to strategic buyers looking to strengthen data capture capabilities at the source. Its Kendall Square location places it within a dense biotech and pharmaceutical ecosystem, which may support customer development and partnership opportunities.

At €600,000, the round is modest and typical of early seed financing. The involvement of Draper B1 as lead and Next Tier Ventures as an additional investor provides initial institutional backing as the company works with laboratories in the US and Spain.

What to Watch

• Adoption and deployment progress with biotech, pharmaceutical, and academic laboratories in the US and Spain
• Depth of integrations with ELN and LIMS platforms, including Benchling and LabArchives
• Development of the voice and computer vision capture stack, including smart glasses hardware
• Expansion of the customer base beyond the current US and Spain footprint

Dimenso's seed round provides capital to advance a platform that sits at the intersection of AI, laboratory instrumentation, and scientific data management—a combination that continues to attract attention from both investors and strategic acquirers in the life sciences technology sector.